we tested the effects of Hsp90
inhibitors on HCV replication in cells carrying an HCV
subgenomic replicon. All of the Hsp90 inhibitors we tested
had potent anti-HCV activity. Using NS2/3 translated in a
rabbit reticulocyte lysate and expressed in Jurkat cells,